318 results
Page 14 of 16
6-K
lnl7u byi
22 Jan 08
Teva to Acquire Cogenesys Acquisition Will Bolster Teva???s Biotechnology Capabilities
12:00am
6-K
k9t31yvq7pfc4894n
3 Dec 07
Early Treatment with Copaxone? Demonstrated Robust Protection Against Progression to Clinically Definite Multiple Sclerosis In the Precise Study
12:00am
6-K
xt3bz1hj
7 Nov 07
First Patient Undergoes Expanded Cord Blood Transplant In the Excell Registration Study of Stemex? for Leukemia and Lymphoma
12:00am
6-K
egmm 1qfvt5yp73n82
7 Nov 07
Initiation of Enrollment In Pivotal Phase III Clinical Study of Oral Laquinimod for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
8q5v 7g2au6
15 Oct 07
Long-term Study Shows Copaxone? Significantly Slows Progression of Disability and Reduces Relapse Rates In Patients with Relapsing-remitting Multiple Sclerosis
12:00am
6-K
t0ow3tv pt3qqd1tw
20 Sep 07
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
12:00am
6-K
gy0u0m9 h3u
7 Jun 07
Teva and Active Biotech to Initiate Pivotal Phase III Trial Program of Oral Laquinimod for Relapsing Multiple Sclerosis
12:00am
6-K
awnli aoy
17 Apr 07
Data Published In Neurology Showed That Higher Dose of Copaxone? Increased Efficacy In Relapsing-remitting Multiple Sclerosis (RRMS)
12:00am
6-K
cajf653 l0ae9vrd8
13 Nov 06
Current report (foreign)
12:00am
6-K
h90vshy td756jgi
3 Oct 06
Study Showed Significant and Sustained Efficacy of Copaxone? Alone Following Short-term Combination Therapy with IV Steroids In Multiple Sclerosis Patients
12:00am
6-K
q376g v39kaaylt
3 Oct 06
Very Active Multiple Sclerosis Patients Benefited from Copaxone? Treatment Following Short-term Induction with Mitoxantrone
12:00am
6-K
i0pmdzm5
5 Sep 06
Laquinimod Phase Iib Trial Confirms Efficacy and Favorable Safety Profile and Shows Significant Reduction In the Rate of Inflammatory Disease Activity
12:00am
6-K
s8lj8yfhdz5zbcrt2
14 Aug 06
Current report (foreign)
12:00am
6-K
r6v7va gvwb7xxd
27 Jul 06
Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-remitting Multiple Sclerosis
12:00am
6-K
r0hsnpoom
6 Apr 06
Teva Announces That Higher Dose of Copaxone? Showed Increased Efficacy In Multiple Sclerosis (MS)
12:00am
6-K
EX-1.1
oyhoc uz43zm0t6mo0o
31 Jan 06
Current report (foreign)
12:00am
6-K
EX-1.3
qlojnh4
31 Jan 06
Current report (foreign)
12:00am